Skip to main content
. 2021 Oct 18;22(6):1456. doi: 10.3892/etm.2021.10891

Figure 2.

Figure 2

Immunohistochemistry staining. (A) Intense, diffuse positivity for CD10; magnification, x100. (B) Tumor cells show nuclear positivity for ER, with variable intensity; magnification, x400. (C) Focal positivity for actin (clone HHF35); magnification, x200. (D) CD34 is negative in the tumor cells and positive in the blood vessels network; magnification, x100. ER, estrogen receptor. HHF35, anti-muscle actin antibody.